Every year, your doctor orders a CBC (Complete Blood Count) and CMP (Comprehensive Metabolic Panel). The results come back with "normal" or "abnormal" flags — benchmarked against a reference range derived from the general American population. That population, where over 40% are obese and 37% have pre-diabetes, is not the right benchmark for longevity optimization.
Serious biohackers know something most patients don't: the same blood tests your doctor orders contain a dozen longevity signals that go completely unread in a standard clinical encounter. Here's how to read them.
What you need: A standard CBC with differential and a CMP (comprehensive metabolic panel) — both ordered together as a "CBC w/diff + CMP." Cost through direct-to-consumer labs (Quest, LabCorp, Ulta Lab Tests): $15–30. Available without a doctor's order in most US states.
The 12 Markers
The single most studied immune aging biomarker. Above 3.0 is associated with a 33% increase in all-cause mortality in large population studies. Calculate it yourself: Absolute Neutrophils ÷ Absolute Lymphocytes. Or enter it in ImmuneSpan for a population-calibrated score.
RDW is one of the most underrated longevity markers. It measures variability in red blood cell size — a proxy for erythropoietic stress, oxidative burden, and inflammatory catabolism. Elevated RDW independently predicts all-cause mortality in every major cohort study it has been tested in, including NHANES (95,000+ records).
Albumin is the primary negative acute-phase protein — it falls when inflammation rises. Declining albumin is one of the earliest measurable signs of chronic inflammatory catabolism. Lab "normal" is ≥3.5 g/dL; longevity-optimized is ≥4.5. Every 0.1 g/dL below 4.5 correlates with increased mortality risk in NHANES data.
Your T-cell and NK-cell reserve. Absolute lymphopenia below 1,500/μL is associated with immune exhaustion, impaired viral surveillance, and elevated cancer risk. In centenarian studies, preserved lymphocyte counts are one of the most consistent immune signatures of exceptional longevity.
Standard CRP (threshold 10 mg/L) misses the inflammaging signal entirely. hsCRP detects chronic low-grade inflammation at the relevant range. Above 1.0 mg/L is associated with increased cardiovascular risk; above 3.0 is a major red flag. Now included in updated cardiovascular risk calculators.
LMR is a companion to NLR — higher is better. Low LMR reflects monocyte-driven chronic inflammation and macrophage hyperactivation. In cancer studies, low LMR predicts worse prognosis across 15+ cancer types. Calculate: Absolute Lymphocytes ÷ Absolute Monocytes.
Clinical "normal" is <100 mg/dL. Longevity-optimal is 72–85. Chronic hyperglycemia (even "normal" range above 90) drives advanced glycation end-products (AGEs) and RAGE signaling — a potent inflammaging mechanism. Every 10 mg/dL above 85 is associated with measurable increases in inflammatory biomarkers.
MPV reflects platelet activation state. Elevated MPV indicates larger, more reactive platelets — a marker of platelet hyperactivation associated with cardiovascular risk and thrombotic tendency. Used in ImmuneSpan's Platelet_Mass calculation (MPV × PLT / 1000) as a composite thromboinflammatory signal.
MCV measures average red blood cell size. Macrocytosis (high MCV) suggests B12/folate deficiency, liver dysfunction, or hypothyroidism. Microcytosis (low MCV) suggests iron deficiency or thalassemia trait. Subtle deviations in the "normal" range carry longevity signal when combined with RDW.
Kidney function is a longevity canary. eGFR naturally declines with age (roughly 1 mL/min/year after 40), but acceleration beyond that signals systemic vascular and inflammatory damage. Even eGFR 60–89 (technically "mildly reduced") is associated with doubled cardiovascular risk vs. >90.
Lab "normal" for ALT is up to 40–56 U/L depending on the lab. Longevity-optimal for men is <25; for women, <19. Elevated ALT (even in "normal" range) signals hepatic inflammation and early NAFLD/MASLD — conditions strongly associated with accelerated systemic inflammaging.
PLR captures the thrombotic-immune intersection. High PLR reflects platelet activation relative to immune surveillance capacity. In cancer patients, PLR above 150 predicts worse outcomes across multiple cancer types. Calculate: Platelets ÷ Absolute Lymphocytes.
How to Track These Over Time
Single readings give you a snapshot. Trends give you the real story. Here's the optimal tracking cadence for a serious biohacker:
- Every 3 months: CBC with differential + CMP + hsCRP (direct-to-consumer, ~$25–50)
- Every 6 months: Add HbA1c, fasting insulin, ferritin, vitamin D, and thyroid panel
- Annually: Add ApoB, Lp(a), and consider an epigenetic clock for a deeper read
Cost reality check: A CBC + CMP + hsCRP ordered through Ulta Lab Tests or LabCorp direct typically costs $20–45 without insurance — less than a supplement bottle. Most people spend hundreds on supplements while ignoring the $30 test that tells them if anything is working.
The Pattern Matters More Than Any Single Marker
No single number tells the whole story. ImmuneSpan's engine uses 64 engineered features from these raw values because the interactions matter — a high NLR with low albumin and high RDW is a very different signal than any one of those in isolation.
Enter your results and get a population-calibrated multi-marker immune wellness score calibrated against 95,000+ NHANES records.
Score All 12 Markers at Once — Free
Enter your CBC and CMP values and get a comprehensive immune wellness score with phenotype identification. No email, no subscription.
Score My Blood Work →This article is for educational purposes only. Optimal range references are derived from published longevity and population research and may differ from your lab's clinical reference ranges. Always discuss blood work values with a qualified healthcare provider before making health decisions.